Suppr超能文献

聚合物预充注射器的环氧乙烷灭菌对储存过程中模型治疗性蛋白化学降解的影响。

Impact of Ethylene Oxide Sterilization of Polymer-Based Prefilled Syringes on Chemical Degradation of a Model Therapeutic Protein During Storage.

机构信息

Terumo Corporation, R&D Center, 1500 Inokuchi, Nakai-machi, Ashigarakami-gun, Kanagawa 259-0151, Japan.

Terumo Corporation, R&D Center, 1500 Inokuchi, Nakai-machi, Ashigarakami-gun, Kanagawa 259-0151, Japan.

出版信息

J Pharm Sci. 2019 Jan;108(1):770-774. doi: 10.1016/j.xphs.2018.09.029. Epub 2018 Oct 5.

Abstract

Materials from prefilled syringe systems-such as silicone oil, tungsten, glass, and rubber-may enhance therapeutic protein aggregation and particle formation. Also, the sterilization method used for syringes may impact aggregation and chemical degradation of biologics during storage. Syringes are generally sterilized by radiation, ethylene oxide gas (EO), or steam. Among the sterilization methods, EO has the potential to cause chemical degradation by the formation of adducts with susceptible amino acid residues in the protein. In this study, EO- and steam-sterilized syringes were compared to determine the influence of residual EO on human serum albumin (HSA) degradation. Although the amount of residual EO in the EO-sterilized syringes was less than 220 μg/syringe, well below the International Organization for Standardization limit, EO adduction to cysteine (Cys) and methionine (Met) in HSA was observed by liquid chromatography and mass spectrometry analysis. The EO adduct ratio of HSA stored for 2 weeks in EO-sterilized syringes was about 45%. In contrast, no chemical degradation was observed in HSA formulation stored in steam-sterilized syringes. Because of the propensity of EO to readily form adducts with proteins, an alternative to EO sterilization should be used for prefilled syringes that will be used for therapeutic protein products.

摘要

预充注射器系统中的材料(如硅油、钨、玻璃和橡胶)可能会增强治疗性蛋白质的聚集和颗粒形成。此外,注射器使用的灭菌方法也可能会影响生物制剂在储存过程中的聚集和化学降解。注射器通常通过辐射、环氧乙烷(EO)气体或蒸汽进行灭菌。在这些灭菌方法中,EO 有形成与蛋白质中易受影响的氨基酸残基加合物的潜力,从而导致化学降解。在这项研究中,比较了 EO 灭菌和蒸汽灭菌的注射器,以确定残留 EO 对人血清白蛋白(HSA)降解的影响。尽管 EO 灭菌注射器中残留 EO 的量低于 220 μg/注射器,远低于国际标准化组织的限量,但通过液相色谱和质谱分析观察到 EO 与 HSA 中的半胱氨酸(Cys)和蛋氨酸(Met)加合。在 EO 灭菌注射器中储存 2 周的 HSA 的 EO 加合物比例约为 45%。相比之下,在蒸汽灭菌注射器中储存的 HSA 制剂未观察到化学降解。由于 EO 很容易与蛋白质形成加合物,因此对于用于治疗性蛋白质产品的预充注射器,应该使用替代 EO 灭菌的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验